amway (malaysia) holdings berhad - … (malaysia) holdings berhad also markets its products under...
TRANSCRIPT
AMWAY (MALAYSIA) HOLDINGS BERHAD Analysis Date:
(AMWAY)
All figures in thousands of Ringgit Malaysia except per share values and ratios
Financial Year: 2012 31/12/2012 Latest Quarter: 31/12/2012
Price: Stock Category: Emerging Investment Grade
Overview
Board: Main Board FBMKLCI: NO
Industry: TRADING SERVICES
Sub-Sector: TRADING AND DISTRIBUTION
Ownership: Corporate Owned (Local)
Institutional Holders Investment Strategy
% Shares Owned: 20.55% Portfolio Strategy: Lump Sum + Top Up
# of Holders: 9 Portfolio Execution:
Total Shares Held: 33,773,133
3 Mo. Net Change: 487,200 Averaging Down Method:
# New Positions: 0
# Closed Positions: 0 Basis for Buying & Selling:
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
Institutional Sponsorship
Market Direction
10/07/2013
2.70
Amway (Malaysia) Holdings Berhad, an investment holding company, distributes consumer products
principally under the Amway name worldwide. The company’s nutrition products include food supplements,
antioxidants, herbal supplements, fortified beverages, weight management, children’s supplements, bee
treasures, tropical herbs, and wellness packs under the NUTRILITE brand; and skin care, cosmetics, and
beauty accessories under the ARTISTRY name. Its personal care products include hair, body, oral, men’s skin,
allano and aloe care, and color creation products; homecare products comprise laundry care, household,
kitchen care, and car care products; and home tech products consist of cookware and cutlery, water
treatment systems, air purifiers, home alarm systems and accessories, and air treatment and cookware
replacement parts. The company’s sourced products comprise home appliances, top garments, fashion
accessories, apparels, leather and small goods, home and décor, equipment, stationery, personal items,
infant/children products, automotive products, houseware and aerosols, food and beverages, and
fragrances. Amway (Malaysia) Holdings Berhad also markets its products under the eSpring, ATMOSPHERE,
iCook, SATINIQUE, L.O.C, and SA8 brands. The company was founded in 1976 and is headquartered in
Petaling Jaya, Malaysia. Amway (Malaysia) Holdings Berhad is a subsidiary of GDA B.V.
Buy and Monitor
Dollar Cost/Value Averaging
Performance
Weekly Chart (Full History)
Price CAGR % 8%
Stock Versus Sector Peers
6.42%2.55% 0.00%
12.23%
39.51%
14.57% 16.53%12.57% 14.09%
69.70%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
Sales - 5Y Growth EPS - 5Y Growth Debt to Equity - 5Y Avg Net Profit Margin - 5YAvg
ROE - 5Y Avg
Stock vs Sector Peers
Company Sector
14.60%
12.22%
6.74%
2.32%
0.00%
2.00%
4.00%
6.00%
8.00%
10.00%
12.00%
14.00%
16.00%
3-Y 5-Y 10-Y Full History
1.26
8.45
9.85
14.86
15.34
25.92
26.74
43.74
0 5 10 15 20 25 30 35 40 45 50
CNI
JAYCORP
HARISON
BERNAS
HAIO
ZHULIAN
DKSH
AMWAY
ROE by Sector Peers
67.94
75.60
212.28
545.91
802.48
1,449.00
1,684.04
1,982.50
0 500 1000 1500 2000 2500
JAYCORP
CNI
HARISON
HAIO
DKSH
ZHULIAN
BERNAS
AMWAY
Market Cap by Sector Peers
6.60
7.49
10.23
10.32
12.35
16.07
19.87
52.50
0 10 20 30 40 50 60
JAYCORP
HARISON
BERNAS
DKSH
ZHULIAN
HAIO
AMWAY
CNI
PE by Sector Peers
Key Ratios
Measures 2003/8/31 2004/8/31 2005/8/31 2006/12/31 2007/12/31 2008/12/31 2009/12/31 2010/12/31 2011/12/31 2012/12/31 5-Y WA. 3-Y WA. 10-Y GR. 5-Y GR. 3-Y GR. Sparkline Grade
Sustainable Competitive Adv. — — — — — — — — — — — — — — — —
Consistent and increasing ROE
(Pref. ≥ 15%)
24.58% 25.99% 26.08% 39.49% 38.91% 40.51% 30.52% 37.13% 46.78% 43.74% 41.93% 43.45% 6.26% 5.80% 8.19%
Consistent and increasing ROIC
(Pref. ≥ 15%)
-246.92% 563.69% 615.82% 2028.18% 450.19% 1241.38% 98.11% 119.79% 141.03% 138.25% 189.90% 135.66% -1.68% -11.40% 0.67%
Increasing Net Profit Margin (Pref.
≥ 10%)
17.51% 15.85% 14.45% 15.45% 20.59% 20.02% 14.89% 15.17% 16.44% 17.19% 16.58% 16.58% 0.11% -2.07% 6.23%
Healthy Cash Flow — — — — — — — — — — — — — — — —
Consistent and increasing CROIC
(Pref. ≥ 15%)
— 278.32% 1054.22% 1972.78% 398.20% 797.31% 52.59% 174.43% 149.54% 119.40% 164.67% 139.13% -26.87% -27.52% -18.95%
Increasing Free Cash Flow / Sales
(Pref. ≥ 5%)
— 5.18% 16.21% 10.07% 13.30% 9.51% 5.91% 16.79% 13.08% 11.13% 11.90% 12.80% 4.38% 11.09% -20.55%
Consistently decreasing (or
negative) Cash Conversion Cycle
-46.34 -30.62 -22.02 -12.24 -9.84 -22.18 -24.09 -19.45 -20.16 -10.05 -16.31 -14.97 9.27% 7.23% 11.34%
Conservative Debt — — — — — — — — — — — — — — — —
Increasing Debt Coverage Ratio
(Pref. ≥ 150%)
— — — — — — — — — — — — — — —
Increasing Quick Ratio (Pref. ≥
100%)
251.82% 229.15% 219.00% 275.94% 269.58% 209.21% 172.55% 147.18% 128.06% 169.44% 157.46% 152.34% -6.84% -7.20% 7.04%
Growth Quality
Column1 2003/8/31 2004/8/31 2005/8/31 2006/12/31 2007/12/31 2008/12/31 2009/12/31 2010/12/31 2011/12/31 2012/12/31
Revenue % 422297 456350 507030 723660 584251 645458 663902 719409 735818 797523
Year over Year — 8.06% 11.11% 42.73% -19.26% 10.48% 2.86% 8.36% 2.28% 8.39%
3-Y Avg. — — 9.14% 23.05% 7.09% -5.72% 6.39% 5.42% 5.14% 5.15%
5-Y Avg. — — — — 11.10% 8.35% 4.25% 1.16% 5.70% 5.26%
10-Y Avg. — — — — — — — — — 6.46%
EBIT % 67621 66515 67610 104085 120312 127481 98874 109149 120986 137066
Year over Year — -1.64% 1.65% 53.95% 15.59% 5.96% -22.44% 10.39% 10.84% 13.29%
3-Y Avg. — — -0.01% 22.39% 28.82% 10.14% -9.81% -7.76% 10.09% 11.39%
5-Y Avg. — — — — 16.00% 18.77% 9.63% -1.01% -1.44% 3.47%
10-Y Avg. — — — — — — — — — 7.78%
Net Income % 52044 53594 51899 80565 87912 95095 72543 78272 89959 99708
Year over Year — 2.98% -3.16% 55.23% 9.12% 8.17% -23.72% 7.90% 14.93% 10.84%
3-Y Avg. — — -0.14% 20.38% 26.35% 8.29% -9.61% -9.73% 10.76% 12.10%
5-Y Avg. — — — — 14.56% 16.74% 8.36% -2.50% -1.49% 3.10%
10-Y Avg. — — — — — — — — — 6.85%
EPS % 0.317 0.326 0.316 0.49 0.535 0.578 0.441 0.4761 0.5472 0.6065
Year over Year — 2.84% -3.07% 55.06% 9.18% 8.04% -23.70% 7.96% 14.93% 10.84%
3-Y Avg. — — -0.16% 20.38% 26.33% 8.26% -9.66% -9.70% 10.79% 12.10%
5-Y Avg. — — — — 14.54% 16.72% 8.32% -2.51% -1.49% 3.12%
10-Y Avg. — — — — — — — — — 6.83%
Cash From Ops. % 70624 24033 57722 61651 76689 95912 45539 94170 93049 90905
Year over Year — -65.97% 140.18% 6.81% 24.39% 25.07% -52.52% 106.79% -1.19% -2.30%
3-Y Avg. — — -10.09% 47.10% 14.21% 22.10% -26.06% -0.92% 35.73% -1.76%
5-Y Avg. — — — — 11.07% 30.52% -0.32% 3.26% 3.68% 6.07%
10-Y Avg. — — — — — — — — — 8.19%
Free Cash Flow % N/A 23646 82176.7 72894.08 77684.13 61409 39216.52 120788.12 96215 88782.25
Year over Year — — 247.53% -11.30% 6.57% -20.95% -36.14% 208.00% -20.34% -7.73%
3-Y Avg. — — — 56.29% -2.81% -8.57% -34.18% 33.82% 44.87% -15.39%
5-Y Avg. — — — — — 18.53% -16.51% 3.27% 11.04% 16.35%
10-Y Avg. — — — — — — — — — 10.15%
0
20,000
40,000
60,000
80,000
100,000
120,000
140,000
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
800,000
900,000
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Growth Quality
Revenue EBIT Net Income Cash From Ops. FCF
Economic Moats
Reference: http://www.cfapubs.org/doi/pdf/10.2469/cp.v30.n2.9
Not available or no moat found
- Looks like AMWAY got very high gross margin: 30%-40%
- AMWAY owns a very strong customer base with loyalty.- Awareness of people in healthcare increases throughout the years.- AMWAY got very huge network of distributors which is a strong army to penetrate different market segment.
- Consumers are usually very loyal to this brand. They do not simply switch to another brand just because of cheaper pricing.
Cost Advantage
Switching Costs
Network Effect
Intangible Assets
Efficient Scale
Not available or no moat found
Red Flags in Financial Statement
Column1 2003/8/31 2004/8/31 2005/8/31 2006/12/31 2007/12/31 2008/12/31 2009/12/31 2010/12/31 2011/12/31 2012/12/31
Revenue 422,297 456,350 507,030 723,660 584,251 645,458 663,902 719,409 735,818 797,523
YoY Changes — 34,053 50,680 216,630 -139,409 61,207 18,444 55,507 16,409 61,705
YoY % — 8.06% 11.11% 42.73% -19.26% 10.48% 2.86% 8.36% 2.28% 8.39%
A/R 8,291 10,989 9,347 10,933 19,146 15,375 9,767 25,774 22,322 31,755
YoY Changes — 2,698 -1,642 1,586 8,213 -3,771 -5,608 16,007 -3,452 9,433
YoY % — 32.54% -14.94% 16.97% 75.12% -19.70% -36.47% 163.89% -13.39% 42.26%
Cash Conversion Cycle -46.34 -30.62 -22.02 -12.24 -9.84 -22.18 -24.09 -19.45 -20.16 -10.05
YoY Changes — 16 9 10 2 -12 -2 5 -1 10
YoY % — 157.18% 33.44% 28.50% 5.45% -26.54% -5.59% 14.41% -1.93% 27.93%
Days In Inventory 39.64 46.31 47.73 31.43 42.03 41.61 46.85 45.21 46.47 45.63
YoY % — 16.83% 3.07% -34.16% 33.73% -1.00% 12.59% -3.49% 2.79% -1.81%
Cash From Ops. 70,624 24,033 57,722 61,651 76,689 95,912 45,539 94,170 93,049 90,905
YoY % — -65.97% 140.18% 6.81% 24.39% 25.07% -52.52% 106.79% -1.19% -2.30%
The financial statement looks normal. No red flag found.
Discounted Cash Flows Valuation 12
Discount Rate
Average risk
premium
Average Risk
free rate
Unadjusted
Discount %
Business Risk
Factor
Financial Risk
Factor
Discount %
Default Value 1.17 0.88 9.35%
Custom Value 1.00
Margin of Safety
Initial RRR Dividend Yield Est. EPS
Growth
Unadjusted
MOS
Business Risk
Factor
Financial Risk
Factor
MOS
Default Value 35% 7% 28%
Custom Value 3%
Growth Estimation
Est. FCF
Growth (Base
Line)
Terminal % Decay Rate
(Yr4E-Yr7E)
Extra Decay
(Yr8E-Yr10E)
Default Value 8% 3% 15% 20%
Custom Value 6%
Financial Figures
Shares Out. 2012 FCFE Excess Cash Intangibles
Assets
Intangibles% add
to DCFDefault Value 164.39 88.78 0%
Custom Value
DCF Summary
7.19% 3.44%
148.86
10.63%
27%3% 1.17 0.88
4.78
Good Base Bad Ugly Good Base Bad Ugly Good Base Bad Ugly
NOSH.
Fair Value 11.46 10.41 9.43 8.52 12.02 10.52 9.20 8.03 12.85 10.55 8.70 7.19
Desired M.O.S.
Buy Under 8.29 7.53 6.82 6.16 8.69 7.60 6.65 5.80 9.29 7.63 6.29 5.20
Current Price
Actual M.O.S. 76% 74% 71% 68% 78% 74% 71% 66% 79% 74% 69% 62%
2.7
3-Y 5-Y 10-Y
164.39
28%
Absolute P/E Valuation Model
Good PE Base PE2 Bad PE3
Expected Earnings Growth 6.00% 12 3.00% 10 0.00% 8
Dividend Yield 5.17% 5 5.17% 5 5.17% 5
Business Risk Factor
Financial Risk Factor
Earnings Visibility Factor
Fair P/E
Current EPS
Fair Price
Margin of Safety
Buy P/E
Buy Price
Expected DPS
Expected Dividend Yield
Sell P/E
Sell Price 9.6011.2312.94
5.60%
14.97 13.26 11.55
21.34 18.52 15.83
0.65
7.26%6.33%
7.018.049.08
27.71%
1.00
0.88
19 17 15
11.60 10.27 8.95
1.00
0.61
EY% OSCILLATOR CALCULATOR
High Low
Green Zone Price($)
6.73% Buy Under RM9.15 10%
1.02%
5.91% Sell Above RM10.42 10%
Red Zone Price($)
Low High
Green Zone EY% 6.83% RM9.01
EY% Price ($)
Red Zone EY% 5.81% RM10.60
Trading Range
0.1312
0.1540
0.16200.1594
0.1404
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
Mar-12 Jun-12 Sep-12 Dec-12 Mar-13
EPS QoQ Growth EPS QoQ Growth: 7.01%
Notes
Created Date Note Type Source Type
10/07/2013 Every valuation model indicates that AMWAY is fully valued as of now. Note -
30/05/2013 http://eresearch.bursamalaysia.com/download.aspx?id=14365&type=research
- buying spurt ahead of several upward price revision
- buying spurt ahead of several upward price revisionWe remain positive on the group’s consistent
growth. Its 3-year sales CAGR is expected to range between 5.5% and 6.4% for FY13 and FY15,
underpinned by the group’s aggressive marketing initiatives and new product launches especially within
the nutrition and healthcare segments. That said, we maintain our core distributor force growth ranging
from 5.3%-5.6% between FY13-FY15.
Outlook Analyst Report
16/11/2012 http://eresearch.bursamalaysia.com/download.aspx?id=13513&type=research
We remain positive on the group’s consistent growth underpinned by its aggressive marketing initiatives
and short term strategies. Some of its strategies include: i)targeting the mass Malay market by providing
more incentives such as Umrah trips as a form of incentive for those achieving their sales targets, ii)
growing its younger distributor force (those younger than 35 years of age), and iii) focusing on the beauty
and wellness range of products. We believe its continued efforts especially in targeting the untapped
Malay market which make up about 60% of the Malaysian population will be its growth driver, going
forward.
Growth Driver;Outlook Analyst Report